Income Tax Expense (Benefit) in USD of 10x Genomics, Inc. from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
10x Genomics, Inc. quarterly/annual Income Tax Expense (Benefit) history and change rate from 2017 to Q3 2025.
  • 10x Genomics, Inc. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was -$733K, a 156% decline year-over-year.
  • 10x Genomics, Inc. Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $3.23M, a 51.4% decline year-over-year.
  • 10x Genomics, Inc. annual Income Tax Expense (Benefit) for 2024 was $4.93M, a 22.2% decline from 2023.
  • 10x Genomics, Inc. annual Income Tax Expense (Benefit) for 2023 was $6.34M, a 57.3% increase from 2022.
  • 10x Genomics, Inc. annual Income Tax Expense (Benefit) for 2022 was $4.03M, a 10.6% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

10x Genomics, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $3.23M -$733K -$2.05M -156% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025
Q2 2025 $5.27M $2.46M +$1.64M +201% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025
Q1 2025 $3.63M $852K -$1.29M -60.3% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025
Q4 2024 $4.93M $648K -$1.71M -72.5% 01 Oct 2024 31 Dec 2024 10-K 13 Feb 2025
Q3 2024 $6.63M $1.32M +$73K +5.88% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025
Q2 2024 $6.56M $818K -$829K -50.3% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025
Q1 2024 $7.39M $2.15M +$1.05M +96.3% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025
Q4 2023 $6.34M $2.35M +$1.55M +193% 01 Oct 2023 31 Dec 2023 10-K 13 Feb 2025
Q3 2023 $4.79M $1.24M -$637K -33.9% 01 Jul 2023 30 Sep 2023 10-Q 29 Oct 2024
Q2 2023 $5.42M $1.65M +$1.02M +163% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $4.4M $1.09M +$374K +52% 01 Jan 2023 31 Mar 2023 10-Q 30 Apr 2024
Q4 2022 $4.03M $804K -$1.65M -67.3% 01 Oct 2022 31 Dec 2022 10-K 13 Feb 2025
Q3 2022 $5.68M $1.88M +$1.36M +259% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023
Q2 2022 $4.33M $627K -$467K -42.7% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023
Q1 2022 $4.79M $719K +$284K +65.3% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q4 2021 $4.51M $2.46M -$4.49M -64.7% 01 Oct 2021 31 Dec 2021 10-K 15 Feb 2024
Q3 2021 $9M $523K -$62K -10.6% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 $9.06M $1.09M +$672K +159% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 $8.39M $435K +$137K +46% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q4 2020 $8.26M $6.95M +$6.84M +6335% 01 Oct 2020 31 Dec 2020 10-K 16 Feb 2023
Q3 2020 $1.41M $585K +$577K +7213% 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021
Q2 2020 $836K $422K +$354K +521% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021
Q1 2020 $482K $298K +$264K +776% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021
Q4 2019 $218K $108K 01 Oct 2019 31 Dec 2019 10-K 18 Feb 2022
Q3 2019 $8K -$8K -50% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 $68K 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020
Q1 2019 $34K 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020
Q3 2018 $16K 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019

10x Genomics, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.93M -$1.41M -22.2% 01 Jan 2024 31 Dec 2024 10-K 13 Feb 2025
2023 $6.34M +$2.31M +57.3% 01 Jan 2023 31 Dec 2023 10-K 13 Feb 2025
2022 $4.03M -$479K -10.6% 01 Jan 2022 31 Dec 2022 10-K 13 Feb 2025
2021 $4.51M -$3.75M -45.4% 01 Jan 2021 31 Dec 2021 10-K 15 Feb 2024
2020 $8.26M +$8.04M +3687% 01 Jan 2020 31 Dec 2020 10-K 16 Feb 2023
2019 $218K +$131K +151% 01 Jan 2019 31 Dec 2019 10-K 18 Feb 2022
2018 $87K +$66K +314% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021
2017 $21K 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.